Healthcare stock that sees 22–25% revenue growth in H2 FY26 despite global challenges
Synopsis: Poly Medicure expects a strong H2 rebound with 22–25% growth, improved exports, and FY26 revenue growth of…
Browsing Tag
Poly Medicure share
1 post